作为药理学点的Farnesoid X受体和纤维细胞生长因子15/19
Syeda Maliha1, Grace L Guo1,2,3,4,5
1Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA.
Liver research
|February 17, 2025
概括
法内索伊德X受体 (FXR) 激动剂和FGF19类似物显示出治疗非酒精性脂肪肝炎 (NASH) 的前景. 研究还在探索FXR对抗性,为这种肝病进行临床前和临床开发的几种候选药物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 药理学 药理学 是一个学科.
背景情况:
- 方氏体X受体 (FXR) 是一个核受体,调节胆酸和胆固醇的平衡,对肝脏和肠道功能至关重要.
- 对FXR信号的失调有助于非酒精性脂肪肝炎 (NASH),这是一个进展性肝病,目前没有FDA批准的治疗方法.
- 小鼠的纤维细胞生长因子15 (FGF15) 和人类的FGF19,一个FXR点基因,在这些代谢途径中发挥作用.
研究的目的:
- 审查目前针对非酒精性脂肪肝炎 (NASH) 胆酸信号的治疗策略.
- 专注于NASH治疗中FXR激动剂和FGF19类型的临床前和临床研究.
- 评估FXR对抗性的潜力,作为NASH的治疗方法.
主要方法:
- 关于小鼠临床前研究和人类临床试验的文献综述.
- 分析FXR及其向基因FGF19在NASH病变发生过程中的作用.
- 在NASH治疗中评估FXR激动剂,FGF19类型和FXR抗剂.
主要成果:
- 几种合成FXR激动剂 (例如,OCA, cilofexor) 和FGF19类似物 (例如,NGM282) 正在NASH的临床试验中.
- 使用UDCA和Gly-MCA等药物的FXR对抗作用正在NASH的临床前研究中.
- 胆酸调节是NASH病理生理学的关键因素,使FXR成为一个重要的治疗点.
结论:
- 通过激动剂或对抗剂进行FXR调制,代表了NASH的有希望的治疗途径.
- 准胆汁酸信号通路为治疗NASH提供了潜在的潜力,NASH是一种具有重大未满足医疗需求的疾病.
- 目前正在进行的临床试验将确定针对NASH患者的FXR向疗法的疗效和安全性.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
Introduction to Fibroblasts
3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)